Studies of two experimental drugs provided fuel for a race to develop medicines to replace blood thinner warfarin for the prevention of blood clots, a global market that could eventually exceed $20 billion a year in revenue.
Race On to Prevent Clots - WSJ.com
Posted by AdanHaggerty49 (#1) 521 days ago (http://online.wsj.com)
Who Voted for this Story
Pligg is an open source content management system that lets you easily create your own social network.